pLV-hUbC-EGFP-sgRNA.FOXA1/A2/A3_CRISPRi
(Plasmid
#216166)
-
PurposeExpress the gRNAs for the human FOXA1/A2/A3-CRISPRi
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 216166 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLV GG hUbV-GFP (EGFP)
- Backbone size w/o insert (bp) 10000
-
Vector typeLentiviral
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namesgRNA-FOXA1-Rank1, sgRNA-FOXA2-Rank2, sgRNA-FOXA2-Rank3, and sgRNA-FOXA3-Rank1
-
gRNA/shRNA sequenceGCAGCCCGCTCACTTCCCG , AAAGACGAGCGCTTACCTC, GTGCCGAGCTGCCCCGAGG and AGCGCTCTGGATCTCTCAG
-
SpeciesH. sapiens (human)
-
Entrez GeneFOXA1 (a.k.a. HNF3A, TCF3A)
-
Entrez GeneFOXA2 (a.k.a. HNF-3-beta, HNF3B, TCF3B)
-
Entrez GeneFOXA3 (a.k.a. FKHH3, HNF3G, TCF3G)
- Promoter phU6, ph7SK, phH1, pmU6
-
Tag
/ Fusion Protein
- EGFP (N terminal on backbone)
Cloning Information
- Cloning method Golden Gate
- 5′ sequencing primer N/A (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byIncorporates the use of Addgene ID 216161 (which was generated from Addgene 84034 and 11680)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLV-hUbC-EGFP-sgRNA.FOXA1/A2/A3_CRISPRi was a gift from Makiko Iwafuchi (Addgene plasmid # 216166 ; http://n2t.net/addgene:216166 ; RRID:Addgene_216166) -
For your References section:
Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate. Matsui S, Granitto M, Buckley M, Ludwig K, Koigi S, Shiley J, Zacharias WJ, Mayhew CN, Lim HW, Iwafuchi M. Mol Cell. 2024 Jan 4:S1097-2765(23)01026-2. doi: 10.1016/j.molcel.2023.12.007. 10.1016/j.molcel.2023.12.007 PubMed 38211589